Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
Abstract Acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) are major problems of public health in intensive care units (ICUs), occurring in 15% of critically ill patients. Among the factors explaining ARDS development, sepsis is known as a frequent cause. Sepsis, ARDS,...
Main Authors: | Nathalie De Freitas Caires, Alexandre Gaudet, Lucie Portier, Anne Tsicopoulos, Daniel Mathieu, Philippe Lassalle |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-018-2222-7 |
Similar Items
-
Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure
by: Maxence Hureau, et al.
Published: (2023-01-01) -
Investigation of Serum Endocan Levels and Age in Critical Inflammatory Conditions
by: Chrysi Keskinidou, et al.
Published: (2023-06-01) -
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
by: Håkon Reikvam, et al.
Published: (2022-03-01) -
The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome
by: Alexandre Gaudet, et al.
Published: (2019-03-01) -
Serum endocan role in diagnosis and prognosis of ventilator associated pneumonia
by: Ashraf Abd El Halim, et al.
Published: (2015-10-01)